• Study to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Austria Denmark France Germany
  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Not yet recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Denmark Hungary +8
  • A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer’s disease

    Not yet recruiting

    4 1
    Investigated diseases:
    Czechia Germany Italy Poland Slovakia Spain
  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Belgium Czechia Denmark France Germany Greece +8
  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Poland +2
  • Study of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

    Not yet recruiting

    1 1 1 1
    Czechia Denmark France Germany Italy The Netherlands +1
  • A study to evaluate the safety of MRM-3379 in men with Fragile X Syndrome

    Not yet recruiting

    2 1
    Investigated diseases:
    Spain
  • A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

    Not yet recruiting

    3 1 1
    Investigated drugs:
    France
  • A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Italy +5

powered by